Thrombosis in individuals with coronary artery illness. Am. J. Cardiol. 1999, 84, 152?56. 132. Kark, J.D.; Selhub, J.; Adler, B.; Gofin, J.; Abramson, J.H.; Friedman, G.; Rosenberg, I.H. Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and girls in jerusalem. Ann. Intern. Med. 1999, 131, 321?30. 133. Wolff, T.; Witkop, C.T.; Miller, T.; Syed, S.B. Folic acid supplementation for the prevention of neural tube defects: An update with the proof for the U.S. Preventive Services Activity Force. Ann. Intern. Med. 2009, 150, 632?39. 134. Eilat-Adar, S.; Goldbourt, U. Nutritional suggestions for preventing coronary heart disease in ladies: Evidence concerning whole foods and supplements. Nutr. Metab. Cardiovasc. Dis. 2010, doi:10.1016/j.numecd.2010.01.011. 135. B aa, K.H.; Nj stad, I.; Ueland, P.M.; Schirmer, H.; Tverdal, A.; Steigen, T.; Wang, H.; Nordrehaug, J.E.; Arnesen, E.; Rasmussen, K.; et al. Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction. N. Engl. J. Med. 2006, 354, 1578?588. 136. Lee, M.; Hong, K.S.; Chang, S.C.; Saver, J.L. Efficacy of homocysteine-lowering therapy with folic acid in stroke prevention: A meta-analysis. Stroke 2010, 41, 1205?212. 137. Jardine, M.J.; Kang, A.; Zoungas, S.; Navaneethan, S.D.; Ninomiya, T.; Nigwekar, S.U.; Gallagher, M.P.; Cass, A.; Strippoli, G.; Perkovic, V. The effect of folic acid primarily based homocysteine lowering on cardiovascular events in people today with kidney illness: Systematic overview and meta-analysis. BMJ 2012, 344, e3533. 138. Plourde, M.; Cunnane, S.C. Very limited synthesis of long chain polyunsaturates in adults: Implications for their dietary essentiality and use as supplements. Appl. Physiol. Nutr. Metab. 2007, 32, 619?34. 139. Neubronner, J.P.; Schuchardt, G.; Kressel, G.; Merkel, M.; von Schacky, C.; Hahn, A.L. Enhanced boost of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters.1025796-31-9 web Eur.1,2-Benzisoxazol-6-amine site J.PMID:33740139 Clin. Nutr. 2011, 65, 247?54. 140. Kris-Etherton, P.M.; Harris, W.S.; Appel, L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106, 2747?757. 141. Gr baek, M. Fish consumption and coronary heart disease mortality. A systematic evaluation of potential cohort studies. Eur. J. Clin. Nutr. 1999, 53, 585?90. 142. Bucher, H.C.; Hengstler, P.; Schindler, C.; Meier, G. N-3 polyunsaturated fatty acids in coronary heart illness: A meta-analysis of randomized controlled trials. Am. J. Med. 2002, 112, 298?04. 143. Studer, M.; Briel, M.; Leimenstoll, B.; Glass, T.R.; Bucher, H.C. Effect of distinct antilipidemic agents and diets on mortality: A systematic assessment. Arch. Intern. Med. 2005, 165, 725?30. 144. Rauch, B.; Schiele, R.; Schneider, S.; Diller, F.; Victor, N.; Gohlke, H.; Gottwik, M.; Steinbeck, G.; del Castillo, U.; Sack, R.; et al. OMEGA, a randomized, placebo-controlled trial to test the effect of hugely purified Omega-3 Fatty Acids on leading of contemporary guideline-adjusted therapy right after myocardial infarction. Circulation 2010, 122, 2152?159. 145. Bosch, J.; Gerstein, H.C.; Dagenais, G.R.; D z, R.; Dyal, L.; Jung, H.; Maggiono, A.P.; Probstfield, J.; Ramachandran, A.; Riddle, M.C. N-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N. Engl. J. Med. 2012, 367, 309?18.Nutrients 2013,146. Kromhout, D.; Giltay, E.J.; Geleijnse, J.M. N-3 fatty acids and cardiovascular events following myocardial infarction. N. Engl. J. M.